California Public Employees Retirement System Reduces Position in Chemed Corporation $CHE

California Public Employees Retirement System cut its holdings in shares of Chemed Corporation (NYSE:CHE) by 17.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 31,520 shares of the company’s stock after selling 6,438 shares during the quarter. California Public Employees Retirement System’s holdings in Chemed were worth $11,906,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Monetary Solutions Ltd acquired a new stake in shares of Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new stake in Chemed during the fourth quarter worth about $26,000. BOK Financial Private Wealth Inc. bought a new position in shares of Chemed during the fourth quarter valued at approximately $27,000. Global Retirement Partners LLC raised its position in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the period. Finally, Rothschild Investment LLC lifted its holdings in shares of Chemed by 800.0% in the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after purchasing an additional 96 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Price Performance

NYSE CHE opened at $510.28 on Friday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $517.74. The business’s fifty day moving average is $458.59 and its two-hundred day moving average is $433.65. The stock has a market capitalization of $6.77 billion, a P/E ratio of 27.81, a P/E/G ratio of 1.85 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the business posted $5.63 EPS. Chemed’s revenue was up 1.6% on a year-over-year basis. On average, research analysts forecast that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s payout ratio is currently 13.08%.

Analysts Set New Price Targets

CHE has been the topic of several analyst reports. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Bank of America increased their target price on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Finally, Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $480.25.

Insider Buying and Selling

In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 3.33% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.